Patents Assigned to CytoSed, Inc.
  • Antibody-linked immuno-sedimentation agent and method of isolating a target form a sample using same
    Patent number: 11782054
    Abstract: The present disclosure is directed to antibody-linked immuno-sedimentation agent, the antibody being linked to a sedimentation agent by a non-antigen binding region of the antibody, and a method of isolating a target from a sample using the antibody-linked immuno-sedimentation agent. The methods involve forming a mixture including a sample with an antibody linked immuno-sedimentation agent and red blood cells under conditions sufficient to form red blood cell rouleaux and allow antibody-antigen binding.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: October 10, 2023
    Assignee: CytoSed, Inc.
    Inventor: Warren L. Dinges
  • ANTIBODY-LINKED IMMUNO-SEDIMENTATION AGENT AND METHOD OF ISOLATING A TARGET FROM A SAMPLE USING SAME
    Publication number: 20130266930
    Abstract: The present disclosure is directed to antibody-linked immuno-sedimentation agent, the antibody being linked to a sedimentation agent by a non-antigen binding region of the antibody, and a method of isolating a target from a sample using the antibody-linked immuno-sedimentation agent. The methods involve forming a mixture including a sample with an antibody linked immuno-sedimentation agent and red blood cells under conditions sufficient to form red blood cell rouleaux and allow antibody-antigen binding.
    Type: Application
    Filed: March 13, 2013
    Publication date: October 10, 2013
    Applicant: CytoSed, Inc.
    Inventor: Warren L. Dinges